Pregnant Cancer Patient Nyari Dies After Failing to Raise Funds for Costly Treatment
The nation is mourning the death of Nyari, a pregnant woman who had been battling cancer since her diagnosis in 2024.
Nyari had been undergoing chemotherapy, but doctors later recommended immunotherapy, a more advanced treatment costing US$5,500 every three weeks.
To complete the first phase of the treatment, she required approximately US$44,000 — an amount that proved difficult to raise.
Before her passing, Nyari had made a heartfelt appeal to well-wishers for financial assistance to access the life-saving treatment.
Similarly, 25-year-old University of Zimbabwe graduate Ruth Hwara, who battled Chronic Kidney Disease, also lost her life after failing to access urgent treatment.
Ruth had been fundraising for a US$30,000 kidney transplant in India.
While well-wishers donated roughly US$70,000, reports later emerged that some funds were misused, allegedly involving her family and intermediaries, delaying her treatment.
These tragedies underscore the harsh realities many patients face in Zimbabwe: even when public generosity is strong, systemic challenges, high medical costs, and issues of accountability can prevent life-saving care from reaching those in need.
